Apr 29 |
Rigel Pharmaceuticals: No Respect With Little Justification, Worth Considering A Buy
|
Apr 12 |
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
|
Apr 10 |
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
|
Mar 12 |
Rigel Pharmaceuticals appoints Lisa Rojkjaer, M.D. as CMO
|
Mar 12 |
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
|
Mar 7 |
Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year
|
Mar 7 |
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript
|
Mar 6 |
Q4 2023 Rigel Pharmaceuticals Inc Earnings Call
|
Mar 6 |
Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL),
|
Mar 6 |
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2023 Earnings Call Transcript
|